Regional immunotherapy for liver and peritoneal metastases.

about

Accelerating progress in the fight against pancreatic cancer Proceedings of the 2017 Leo and Anne Albert Symposium for Pancreatic Cancer Research.The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.

P2860

Q47574066-C584FC26-AA66-4180-BBF8-6E6CF3F09169 Q49843616-094EEABC-07AA-441F-9A59-F6E0B09B32DA

P2860

Regional immunotherapy for liver and peritoneal metastases.

Item

http://www.wikidata.org/entity/Q39329364

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Regional immunotherapy for liver and peritoneal metastases.

@en

Regional immunotherapy for liver and peritoneal metastases.

@nl

type

Item

label

Regional immunotherapy for liver and peritoneal metastases.

@en

Regional immunotherapy for liver and peritoneal metastases.

@nl

prefLabel

Regional immunotherapy for liver and peritoneal metastases.

@en

Regional immunotherapy for liver and peritoneal metastases.

@nl

P1476

Regional immunotherapy for liver and peritoneal metastases.

@en

P2093

Jeffrey Reha

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Cancer; a biological approach. I. The processes of control

Special cancer microenvironment in human colonic cancer: Concept of cancer microenvironment formed by peritoneal invasion (CMPI) and implication of subperitoneal fibroblast in cancer progression

CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition

The blockade of immune checkpoints in cancer immunotherapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

P304

46-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24641

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Steven C Katz

P577

2017-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28543176

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Regional immunotherapy for liver and peritoneal metastases.

about

P2860

P2860

Regional immunotherapy for liver and peritoneal metastases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921